Literature DB >> 35746935

Psychiatric Applications of Repetitive Transcranial Magnetic Stimulation.

Katharine G Marder1, Tracy Barbour1, Stephen Ferber1, Olanike Idowu1, Amanda Itzkoff1.   

Abstract

Transcranial magnetic stimulation (TMS) is an increasingly popular noninvasive brain stimulation modality. In TMS, a pulsed magnetic field is used to noninvasively stimulate a targeted brain region. Repeated stimulation produces lasting changes in brain activity via mechanisms of synaptic plasticity similar to long-term potentiation. Local application of TMS alters activity in distant, functionally connected brain regions, indicating that TMS modulates activity of cortical networks. TMS has been approved by the U.S. Food and Drug Administration for the treatment of major depressive disorder, obsessive-compulsive disorder, and smoking cessation, and a growing evidence base supports its efficacy in the treatment of other neuropsychiatric conditions. TMS is rapidly becoming part of the standard of care for treatment-resistant depression, where it yields response rates of 40%-60%. TMS is generally safe and well tolerated; its most serious risk is seizure, which occurs very rarely. This review aims to familiarize practicing psychiatrists with basic principles of TMS, including target localization, commonly used treatment protocols and their outcomes, and safety and tolerability. Practical considerations, including evaluation and monitoring of patients undergoing TMS, device selection, treatment setting, and insurance reimbursement, are also reviewed.
Copyright © 2022 by the American Psychiatric Association.

Entities:  

Keywords:  Repetitive transcranial magnetic stimulation; Transcranial magnetic stimulation; major depressive disorder; obsessive-compulsive disorder; smoking cessation

Year:  2022        PMID: 35746935      PMCID: PMC9063593          DOI: 10.1176/appi.focus.20210021

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  74 in total

1.  Assessment of standard coil positioning in transcranial magnetic stimulation in depression.

Authors:  Cecilia Nauczyciel; Pierre Hellier; Xavier Morandi; Sophie Blestel; Dominique Drapier; Jean Christophe Ferre; Christian Barillot; Bruno Millet
Journal:  Psychiatry Res       Date:  2010-08-07       Impact factor: 3.222

Review 2.  Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials.

Authors:  Jianjun Chen; Chuanjuan Zhou; Bo Wu; Ying Wang; Qi Li; Youdong Wei; Deyu Yang; Jun Mu; Dan Zhu; Dezhi Zou; Peng Xie
Journal:  Psychiatry Res       Date:  2013-10-07       Impact factor: 3.222

3.  Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients.

Authors:  A M Speer; T A Kimbrell; E M Wassermann; J D Repella; M W Willis; P Herscovitch; R M Post
Journal:  Biol Psychiatry       Date:  2000-12-15       Impact factor: 13.382

4.  Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.

Authors:  Linda L Carpenter; Philip G Janicak; Scott T Aaronson; Terrence Boyadjis; David G Brock; Ian A Cook; David L Dunner; Karl Lanocha; H Brent Solvason; Mark A Demitrack
Journal:  Depress Anxiety       Date:  2012-06-11       Impact factor: 6.505

5.  The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD).

Authors:  Juliana Corlier; Linda L Carpenter; Andrew C Wilson; Eric Tirrell; A Polly Gobin; Brian Kavanaugh; Andrew F Leuchter
Journal:  Brain Stimul       Date:  2019-07-25       Impact factor: 8.955

6.  5Hz Repetitive transcranial magnetic stimulation to left prefrontal cortex for major depression.

Authors:  Noah S Philip; S Louisa Carpenter; Samuel J Ridout; George Sanchez; Sarah E Albright; Audrey R Tyrka; Lawrence H Price; Linda L Carpenter
Journal:  J Affect Disord       Date:  2015-07-17       Impact factor: 4.839

Review 7.  Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).

Authors:  Jean-Pascal Lefaucheur; Nathalie André-Obadia; Andrea Antal; Samar S Ayache; Chris Baeken; David H Benninger; Roberto M Cantello; Massimo Cincotta; Mamede de Carvalho; Dirk De Ridder; Hervé Devanne; Vincenzo Di Lazzaro; Saša R Filipović; Friedhelm C Hummel; Satu K Jääskeläinen; Vasilios K Kimiskidis; Giacomo Koch; Berthold Langguth; Thomas Nyffeler; Antonio Oliviero; Frank Padberg; Emmanuel Poulet; Simone Rossi; Paolo Maria Rossini; John C Rothwell; Carlos Schönfeldt-Lecuona; Hartwig R Siebner; Christina W Slotema; Charlotte J Stagg; Josep Valls-Sole; Ulf Ziemann; Walter Paulus; Luis Garcia-Larrea
Journal:  Clin Neurophysiol       Date:  2014-06-05       Impact factor: 3.708

8.  Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression.

Authors:  M S George; E M Wassermann; W A Williams; A Callahan; T A Ketter; P Basser; M Hallett; R M Post
Journal:  Neuroreport       Date:  1995-10-02       Impact factor: 1.837

9.  1Hz rTMS of the right orbitofrontal cortex for major depression: Safety, tolerability and clinical outcomes.

Authors:  Kfir Feffer; Peter Fettes; Peter Giacobbe; Zafiris J Daskalakis; Daniel M Blumberger; Jonathan Downar
Journal:  Eur Neuropsychopharmacol       Date:  2017-11-17       Impact factor: 4.600

10.  Concordance Between BeamF3 and MRI-neuronavigated Target Sites for Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex.

Authors:  Arsalan Mir-Moghtadaei; Ruth Caballero; Peter Fried; Michael D Fox; Katherine Lee; Peter Giacobbe; Zafiris J Daskalakis; Daniel M Blumberger; Jonathan Downar
Journal:  Brain Stimul       Date:  2015-05-29       Impact factor: 8.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.